selected publications

• article

  • Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: An across-study comparison.  RMD Open.  7:-. 2021-01-01
  • Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial.  The Lancet Rheumatology.  3:e122-e130. 2021-01-01
  • A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.  Arthritis Research and Therapy.  18:-. 2016-01-01